Why CureVac (CVAC) Shares Are Volatile
CureVac shares have been volatile over the past week, gaining some 25%. The stock has seen increased trading volume following ...
Why CureVac (CVAC) Stock Is Rising
Shares of CureVac are trading higher by 15% during Monday's session. The stock is gaining following a CDC report highlighting ...
bovnews23h
Why Did Leerink Partners Give CureVac BV (CVAC) Stock Market Perform Rating?
Leerink Partners has recently reduced CureVac BV (CVAC) stock to Market Perform rating, as announced on April 25, 2024, according to Finviz. Earlier, on June 8, 2023, SVB Securities had initiated the ...
CureVac: Latest GBM Data Bodes Well For Next Program Check Point
CureVac recently released new clinical data. Why should investors care? Click here to find out why I am bullish on CVAC stock ...
bovnews3d
CureVac BV (CVAC) Stock Rated Market Perform by Leerink Partners
CureVac BV (CVAC) stock saw a modest uptick, ending the day at $4.44 which represents a slight increase of $0.82 or 22.65% from the prior close of $3.62. The stock opened at $4.14 and touched a low of ...
Arbutus could benefit from Big Pharma bird flu vaccines: Jefferies
Jefferies sees Arbutus (NASDAQ:ABUS) potentially benefitting from vaccines being developed by Moderna (MRNA) and Pfizer (PFE) ...
Moderna, Novavax and other vaccine names extend gains amid COVID/flu concerns
Novavax (NVAX) and other vaccine developers rise as Investors react to rising flu and COVID-19 cases in the U.S. Read more ...